The variability in prevalence rates sets unclear indications for diagnosis and prophylaxis. In a UK survey, 84% of hospitals lacked routine prophylaxis for patients with ankle fractures requiring plaster casts and 64% did not perform DVT risk assessment. 19 The American College of Chest Physicians do not recommend prophylaxis for isolated injuries distal to the knee. 10 The aim of this pilot study is to evaluate the prevalence and risk factors of DVT in patients with ankle and foot fractures treated with nonoperative management.
Methods
This prospective cross-sectional pilot study was conducted in an outpatient orthopedic fracture clinic of a tertiary hospital in Sydney, Australia. Between February and August 2014, consecutive patients ! 18 years of age with a radiologically confirmed ankle or foot fracture treated nonsurgically were identified at the clinic and recruited. An ankle fracture included lateral or medial malleoli and the distal tibiofibular, tibiotalar, or subtalar joint. A foot fracture included any bone distal to the subtalar joint. Exclusion criteria included the following: multitrauma, prior venous thromboembolism (VTE), current use of anticoagulant or antiplatelet agents, or presented to the clinic outside the 7 to 90 day postfracture period. All enrolled patients provided written informed consent.
Baseline demographic data, time to clinic follow-up, and ultrasound assessment since injury, DVT symptoms and specific DVT risk factors were recorded using a standardized questionnaire at the time of recruitment. Risk factors included age, gender, BMI, smoking status, use of OCP, use of HRT, history of active cancer, history of bleeding or clotting disorder, family history of DVT, method of immobilization, and weight-bearing status on discharge from the Department. 4, 5, 8, 9, 18 Patients were referred for compression duplex ultrasonography (CDUS) of the lower limb with the fracture. If a DVT was found, the contralateral leg was also scanned and the patient was referred to a vascular specialist for appropriate treatment. Distal DVT was defined as a thrombus in the deep veins of the calf including axial and muscular named deep veins. Thrombus in veins including or proximal to the popliteal vein was classified as proximal DVT. If CDUS was completed on a day after recruitment, time to CDUS was adjusted accordingly. Recruited patients were contacted by phone to confirm their participation if no result was available after 2 weeks. The study was approved by the hospital's Human Ethics Research Committee (Approval number: LNR/13/SVH/397).
Statistical Analysis
Continuous and categorical variables were reported as medians, means, and proportions with 95% CIs. Nonparametric data underwent log 10 transformation before testing significance. Patient characteristics and risk factors were assessed with independent t-test for continuous variables and Fisher exact test for categorical variables. Data were adjusted with bootstrapping (no. of resamples ¼ 1,000) in all analyzes. A p value 0.05 was considered to be significant. All data were analyzed with SPSS v22.0 (Statiscal Package for Social Sciences; IBM, Armonk, NY).
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Results
During the study period, 116 patients treated with surgery presented to the clinic while 162 patients with nonsurgical ankle and foot fractures were identified. Overall, 90 patients were excluded (current anticoagulation or antiplatelet therapy, n ¼ 9; multitrauma, n ¼ 7; prior VTE, n ¼ 3; presented outside the 7-to 90-day time period, n ¼ 35; declined consent or did not attend the clinic, n ¼ 36) leaving 72 patients for analysis. The characteristics and DVT risk-specific factors of the study cohort are shown in ►Table 1. During the 6 months, there was significant loss to followup with 35 patients receiving a CDUS (CDUS-R) while the remaining patients were nonresponders (n ¼ 37). These were patients who were recruited into the study, completed the questionnaire, referred for CDUS but did not attend and were lost to follow-up. In the CDUS-R group, 23% of patients (95% CI, 11.4-37.1; n ¼ 8) were positive for DVT; seven distal DVT and one proximal DVT. Half of this group (n ¼ 4) reported symptoms at the time of recruitment meaning the vast majority of the CDUS-R group were asymptomatic. Lack of symptoms was statistically significant for not developing a DVT (p ¼ 0.006). The pertinent features of the eight patients with DVT are shown in ►Table 2.
Nonresponders were also mostly asymptomatic with only four patients reporting DVT symptoms-two had calf pain, one had calf swelling, and one had both pain and swelling. The characteristics of this group are outlined in ►Table 3.
Median follow-up time at the clinic postfracture was 23 days (range, 7-90 days) and the median time to CDUS from day of injury was 32 days (range, 7-90 days). Majority of patients (69%) and the CDUS-R group (71%) had their fracture immobilized with a controlled ankle movement walker (CAMboot). The characteristics and risk factors between CDUS-R patients with and without DVT are compared in ►Table 4. The mean age of patients with DVT was 53 AE 1.3 SD (p ¼ 0.011) and age ! 45 was statistically significant (p ¼ 0.013).
Discussion
The prevalence of DVT in patients recovering from an ankle or foot fracture with nonoperative management was 23% after undergoing CDUS. Suboptimal patient adherence to CDUS strongly suggests that our results must be interpreted with caution. However, as majority of the patients with CDUS-R without DVT were asymptomatic (96.3%), if we assume this was a consistent trend asymptomatic nonresponders (89.2%) would then likely have scanned negative for DVT. Applying this assumption to the whole sample, results in an extrapolated prevalence of 11% (8/72; 95% CI, 5.6-18.1). As a best conservative estimate, this still exceeds the highest reported prevalence of 5% in comparable studies. Therefore, despite the low numbers in our study, the prevalence of DVT in this subgroup of orthopedic patients may be under recognized. There are few published studies that specifically identify the prevalence of DVT in patients with ankle and foot fractures exclusively. 21 14, 25 It is possible in our study that the patients who had later scans may have already underwent recanalization leading to an underestimated prevalence rate.
Aside from age, all other risk factors we assessed did not show statistical significance although numerous studies have shown otherwise. Riou et al demonstrated that rigid immobilization (p < 0.0001) was an independent significant risk factor for DVT along with age older than 50 years (p < 0.0001), severe injury (defined as fracture, dislocation, or tendon rupture; p < 0.0002), and nonweight bearing (p < 0.0015).
15 A combination of three or more risk factors (p ¼ 0.01) significantly increases the incidence of DVT 13 as the incidence increases proportionally with the number of risk factors.
18,24,27
Most studies conclude thromboprophylaxis and ultrasound screening is not routinely indicated in patients with ankle and foot fractures. We observed a prevalence of 11% (8/72) with a modest data set and large loss to follow-up so our results must interpreted with caution. However, it casts light back onto the question that risk assessment and stratification for DVT should be considered for patients postfracture in the ankle or foot.
9,10,25,27,31 This may identify higher risk individuals and facilitate early DVT prophylaxis or monitoring. This pilot study has unveiled limitations and logistical issues to be addressed in the future. Notably, the limitations include the small number of patients and the low adherence to attending ultrasound assessment. Logistically, it was not possible to perform ultrasonography for patients at enrolment. The lack of lower limb symptoms, impaired subject mobility, and understaffed ultrasound clinic may have contributed to low compliance with CDUS. As the study was conducted at only one site and with low subject numbers, generalization of the results is not reliable. A larger prospective study in the future is feasible utilizing multiple study sites to further explore our results with minimal loss to follow-up.
Conclusion
As far as we know, this pilot study is the first study in Australia to investigate the prevalence of this disease in this specific subgroup of patients. We found a prevalence of 11% of DVT, with age ! 45 years being a significant risk factor for DVT. Future larger scale prospective studies of higher power are warranted to confirm this prevalence of DVT and this may result in reevaluation of current VTE prophylaxis guidelines in this patient group.
